Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1996
Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients
B Rosenkranz
Fundamental & Clinical Pharmacology
|
January 1, 1990
Phase I studies: what to measure?
B Rosenkranz
Thrombosis Research
|
January 1, 1987
Mechanism of vasopressin-induced platelet aggregation
J Filep, B Rosenkranz
Analytical and Bioanalytical Chemistry
|
August 13, 2002
Rapid separation of elemental species by multicapillary GC
B Rosenkranz, J Bettmer
Therapeutic Drug Monitoring
|
January 1, 1985
Falsely elevated digoxin concentrations in patients with liver disease
B Rosenkranz, J C Frölich
Prostaglandins, Leukotrienes, and Medicine
|
September 1, 1985
Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid
B Rosenkranz, J C Frölich
Schmerz (Berlin, Germany)
|
October 28, 1996
[Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers]
E Freye, B Rosenkranz, B Neruda
Infection
|
September 1, 1990
Pharmacokinetics of cefotaxime in patients after liver transplantation
E Kuse, P Vogt, B Rosenkranz
Clinical Pharmacology and Therapeutics
|
December 1, 1985
Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam
U Klotz, P Arvela, B Rosenkranz
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1988
Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure
N Lameire, B Rosenkranz, D Brockmeier
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1996
Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients
B Rosenkranz
Fundamental & Clinical Pharmacology
|
January 1, 1990
Phase I studies: what to measure?
B Rosenkranz
Thrombosis Research
|
January 1, 1987
Mechanism of vasopressin-induced platelet aggregation
J Filep, B Rosenkranz
Analytical and Bioanalytical Chemistry
|
August 13, 2002
Rapid separation of elemental species by multicapillary GC
B Rosenkranz, J Bettmer
Therapeutic Drug Monitoring
|
January 1, 1985
Falsely elevated digoxin concentrations in patients with liver disease
B Rosenkranz, J C Frölich
Prostaglandins, Leukotrienes, and Medicine
|
September 1, 1985
Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid
B Rosenkranz, J C Frölich
Schmerz (Berlin, Germany)
|
October 28, 1996
[Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers]
E Freye, B Rosenkranz, B Neruda
Infection
|
September 1, 1990
Pharmacokinetics of cefotaxime in patients after liver transplantation
E Kuse, P Vogt, B Rosenkranz
Clinical Pharmacology and Therapeutics
|
December 1, 1985
Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam
U Klotz, P Arvela, B Rosenkranz
Scandinavian Journal of Gastroenterology. Supplement
|
January 1, 1988
Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure
N Lameire, B Rosenkranz, D Brockmeier
Page
of 5